# Steroids, Hyaluronic Acid or Platelet Rich Plasma Versus Placebo for the Knee Osteoarthritis

> **NCT02776514** · PHASE2 · COMPLETED · sponsor: **Balgrist University Hospital** · enrollment: 120 (actual)

## Conditions studied

- Osteoarthritis, Knee

## Interventions

- **DRUG:** Triamcort
- **DRUG:** Platelet-rich-plasma
- **DRUG:** Suplasyn1
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02776514
- **Lead sponsor:** Balgrist University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2020-11
- **Final completion:** 2020-11
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2022-02-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02776514

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02776514, "Steroids, Hyaluronic Acid or Platelet Rich Plasma Versus Placebo for the Knee Osteoarthritis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02776514. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*